Profile
Steven A. Cantor is the founder of Vaso Corp.
and bioAffinity Technologies, Inc. He previously worked as the Manager of Business Development at Neurox Pharmaceuticals LLC from 2011 to 2014, Co-Chief Executive Officer & Director at enVVeno Medical Corp.
from 2017 to 2018, and Chairman at Crown Equity Holdings, Inc. in 2018 to 2019.
Former positions of Steven Cantor
| Companies | Position | End |
|---|---|---|
| CROWN EQUITY HOLDINGS INC. | Chairman | 08/01/2019 |
| ENVVENO MEDICAL CORPORATION | Chief Executive Officer | 31/03/2018 |
| BIOAFFINITY TECHNOLOGIES, INC. | Founder | 30/04/2014 |
Neurox Pharmaceuticals LLC
Neurox Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Corporate Officer/Principal | 31/12/2013 |
| VASO CORPORATION | Chief Executive Officer | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Vaso Corp.
Vaso Corp. Information Technology ServicesTechnology Services Engages in the healthcare equipment and information technology industries | Technology Services |
enVVeno Medical Corp.
enVVeno Medical Corp. Medical SpecialtiesHealth Technology Specializes in biological cardiovascular implants | Health Technology |
Crown Equity Holdings, Inc.
Crown Equity Holdings, Inc. Advertising/Marketing ServicesCommercial Services Operates as a holding company whose subsidiaries provides computer related services | Commercial Services |
bioAffinity Technologies, Inc.
bioAffinity Technologies, Inc. Medical SpecialtiesHealth Technology Develops vitro diagnostic tests and targeted cancer therapeutics for early-stage cancer diagnostics | Health Technology |
Neurox Pharmaceuticals LLC
Neurox Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
- Stock Market
- Insiders
- Steven Cantor
















